|
- 积分
- 219
- 威望
- 219
- 包包
- 2027
|
1.Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke., V9 m: p. `9 \; Z) j
Hayase M, Kitada M, Wakao S, Itokazu Y, Nozaki K, Hashimoto N, Takagi Y, Dezawa M.4 p: E/ i+ N- n( ]! U$ ?7 ?
JCereb Blood Flow Metab. 2009 Aug;29(8):1409-20. Epub 2009 May 13.
' I O {( j+ `- b) l0 w3 e5 m5 U) W4 t
2.Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.
1 n' ]" ]" g, P9 z W. Z% G7 A$ xGlavaski-Joksimovic A, Virag T, Chang QA, West NC, Mangatu TA, McGrogan MP, Dugich-Djordjevic M, Bohn MC.
/ E, g& m# i$ iCell Transplant. 2009;18(7):801-14. Epub 2009 Sep 28.3 L) A2 ^; W6 Q* F% C0 ~
4 v7 `4 c; Y! v3 O! H
3.Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease., r: K* U0 }/ K" Z$ a3 h
Glavaski-Joksimovic A, Virag T, Mangatu TA, McGrogan M, Wang XS, Bohn MC.
% T' y* T/ T1 ]/ W1 RJ Neurosci Res. 2010 Sep;88(12):2669-81. |
|
发表于 2011-8-9 20:58
